Press release
CRISPR Gene Editing in Infectious Diseases Market is expected to reach USD 8.92 billion in 2034
CRISPR Gene Editing in Infectious Diseases
The CRISPR Gene Editing in Infectious Diseases Market is witnessing rapid expansion, driven by growing applications of CRISPR-based tools in viral, bacterial, and fungal disease diagnostics and therapeutics. In 2024, the market was valued at USD 1.64 billion, reflecting strong adoption in academic research, genomic surveillance, and early-stage drug development programs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73646
By 2034, the market is expected to reach USD 8.92 billion, progressing at a remarkable 18.4% CAGR due to breakthroughs in CRISPR-based antiviral therapies, point-of-care diagnostics, and precision gene editing platforms. The post-pandemic era has highlighted the importance of tools that can provide rapid, accurate, and scalable solutions for pathogen detection and genome manipulation. CRISPR technologies such as Cas9, Cas12, Cas13, and prime editing are now being integrated across major infectious disease research pipelines.
Increasing investments from biotech companies, government funding for emerging pathogen surveillance, and the rise of synthetic biology-based therapeutics further underscore the market's strong growth potential.
Key Market Drivers
• Surge in infectious disease outbreaks and global genomic surveillance programs
• Expansion of CRISPR-based diagnostics such as CRISPR-Cas12/13 rapid detection kits
• Increased research in viral genome targeting, particularly for HIV, influenza, COVID-19, and HBV
• Growth in investment for gene therapy and synthetic biology
• Rising adoption in antimicrobial resistance (AMR) studies
• Accelerated regulatory pathways for innovative genetic tools
• Collaboration between biotech firms and academia for CRISPR therapeutic development
Market Restraints
• Safety concerns related to off-target gene editing
• Strict regulatory frameworks governing genetic modification
• High cost of CRISPR reagent kits and specialized laboratory equipment
• Ethical concerns related to human germline editing
• Limited availability of skilled researchers and infrastructure in emerging regions
Market Segmentation
By Product Type
• CRISPR Gene Editing Kits
• CRISPR Enzymes (Cas9, Cas12, Cas13)
• Guide RNA (gRNA) Products
• CRISPR Plasmids & Vectors
• CRISPR-Based Diagnostic Assay Kits
• Delivery Systems (Lipid Nanoparticles, Viral Vectors, Electroporation)
By Application
• Viral Diseases (HIV, COVID-19, Influenza, HBV, HCV)
• Bacterial Diseases (Tuberculosis, MRSA, AMR studies)
• Parasitic Diseases (Malaria, Leishmaniasis)
• Fungal Infections
• Genomic Surveillance & Epidemiology
• Drug Discovery & Development
By End User
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Diagnostic Laboratories
• Hospitals & Clinical Centers
• Government & Public Health Agencies
By Technology
• CRISPR-Cas9
• CRISPR-Cas12 (DETECTR)
• CRISPR-Cas13 (SHERLOCK)
• Base Editing
• Prime Editing
• CRISPR Interference (CRISPRi) & CRISPR Activation (CRISPRa)
Explore Full Report here: https://exactitudeconsultancy.com/reports/73646/crispr-gene-editing-in-infectious-diseases-market
Regional Analysis
North America
• Market share (2024): ~42%
• Largest hub for CRISPR research, high adoption in biotech, NIH-backed funding, and early regulatory acceptance.
• Strong ecosystem of CRISPR startups and genomic surveillance programs.
Europe
• Market share (2024): ~28%
• Growth driven by EU-sponsored infectious disease research programs and investments in AMR genomic studies.
• Significant progress in CRISPR diagnostics and public health initiatives.
Asia Pacific
• Fastest-growing region (CAGR: ~22% through 2034)
• Expanding biotech R&D in China, Japan, South Korea, Singapore, and India.
• Rising infectious disease burden and increased government funding for genomic innovation.
Latin America & Middle East/Africa
• Emerging markets adopting CRISPR-based diagnostics for regional outbreaks.
• Improvement in laboratory infrastructure accelerating uptake.
Competitive Landscape (20 Key Players)
1. CRISPR Therapeutics
2. Editas Medicine
3. Intellia Therapeutics
4. Mammoth Biosciences
5. Sherlock Biosciences
6. Caribou Biosciences
7. Beam Therapeutics
8. Synthego Corporation
9. Horizon Discovery
10. AstraZeneca
11. GeneCopoeia
12. Takara Bio Inc.
13. Thermo Fisher Scientific
14. New England Biolabs (NEB)
15. QIAGEN
16. Merck KGaA (Sigma-Aldrich)
17. Genscript Biotech Corporation
18. Agilent Technologies
19. Danaher Corporation
20. Becton Dickinson & Company
These companies are focusing on CRISPR therapeutic pipelines, diagnostic kits, research reagents, cloud-enabled bioinformatics, and delivery technology innovations.
Recent Developments
• 2024: Mammoth Biosciences introduced a next-generation CRISPR-based multi-pathogen detection platform.
• 2024: Intellia and Regeneron expanded their collaboration to target viral diseases using in vivo CRISPR therapies.
• 2023-2024: Sherlock Biosciences launched upgraded SHERLOCK CRISPR diagnostic kits for respiratory infections.
• 2024: CRISPR Therapeutics entered preclinical trials for CRISPR-based antiviral platforms targeting influenza and HIV.
• 2024: Several companies began applying CRISPR tools for AMR gene mapping in bacteria.
• EU: Increased Horizon Europe funding for CRISPR-enabled epidemiological surveillance of emerging pathogens.
Opportunities
• Development of CRISPR-based cures for chronic viral infections (HIV, HBV, HPV).
• Rapid, decentralized point-of-care testing for pandemic preparedness.
• Synthetic biology-driven programmable antimicrobials.
• High-precision gene editing systems (prime editing) for infectious diseases.
• AI-driven design of gRNA for pathogen genome mapping.
• Expansion in emerging markets through low-cost CRISPR diagnostic kits.
Conclusion
The CRISPR Gene Editing in Infectious Diseases Market is entering a breakthrough phase, propelled by strong demand for rapid diagnostics, genome-targeted therapeutics, and precision surveillance technologies. With a projected market value of USD 8.92 billion by 2034 and an impressive 18.4% CAGR, CRISPR-based solutions are set to play a pivotal role in the next decade of infectious disease control and clinical innovation.
North America remains the global leader, while Asia Pacific is emerging as the fastest-growing market. Increasing collaborations, strategic investments, and regulatory support will continue to open new avenues for CRISPR-enabled breakthroughs across the infectious diseases ecosystem.
This report is also available in the following languages : Japanese (感染症におけるCRISPR遺伝子編集:市場), Korean (감염성 질환에서의 CRISPR 유전자 편집: 시장), Chinese (CRISPR基因编辑在传染病领域的应用:市场), French (Édition génique CRISPR dans les maladies infectieuses : marché), German (CRISPR-Geneditierung bei Infektionskrankheiten: Markt), and Italian (Editing genetico CRISPR nelle malattie infettive: mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73646
Our More Reports:
PERK Inhibitors Market
https://exactitudeconsultancy.com/reports/72667/perk-inhibitors-market
CRISPR Gene Editing Therapies Market
https://exactitudeconsultancy.com/reports/72861/crispr-gene-editing-therapies-market
DNA Encoded Library Market
https://exactitudeconsultancy.com/reports/73115/dna-encoded-library-market
Metabolic and Cardiology Stem Cells Market
https://exactitudeconsultancy.com/reports/73138/metabolic-and-cardiology-stem-cells-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CRISPR Gene Editing in Infectious Diseases Market is expected to reach USD 8.92 billion in 2034 here
News-ID: 4294423 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for CRISPR
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about…
